Moleculin Biotech Inc (NASDAQ:MBRX) traded at $0.58 at close of the session on Friday, June 20 and made an upward move of 0.27% on its previous day’s price.
Looking at the stock we see that its previous close was $9.33 and the beta (5Y monthly) reads 1.565 with the day’s price range being $0.25 – $0.34. In terms of its 52-week price range, MBRX has a high of $4.71 and a low of $0.40. The company’s stock has lost about -72.75% over that past 30 days.
Moleculin Biotech Inc has a market cap of $3.77 million and is expected to release its quarterly earnings report on 2025-May-13.
Looking further, we note the current price level is 17 off its SMA20 and 8.25 from its 50-day simple moving average. The beta value is -98.72%, while the average true range (ATR) is currently pointing at -99.74%.
Coming back to Moleculin Biotech Inc (NASDAQ:MBRX), we note that the average 3-month trading volume was 26.73, while that of the preceding 10-day period stands at 2.19 million. Current shares outstanding are 14.13 million.
The insiders hold 0.84% of the company’s shares while institutions hold 10.46%. The data shows that short shares as of 2025-05-30, stood at 0.6 million at a short ratio of 1.85. This represents a 430.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 0.73 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -93.22% down in year-to-date price movement.
